These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 406600)

  • 1. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 5. Mode of action of anti-tubercular drugs.
    Santhanam K; Venkitasubramanian TA
    Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):192-207. PubMed ID: 96023
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 7. Early results from indirect drug susceptibility test for tubercle bacilli.
    Mathew S; Narayanan A; Segaran R; Paramasivan CN
    Indian J Med Res; 1999 May; 109():167-9. PubMed ID: 10643140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies on the influence of dimethylsulfoxide (DMSO) on reversion to sensitivity to isonicotinic acid hydrazide (INH) and rifampicin (RMP) in resistant strains of tubercle bacilli.
    Szydłowska T; Pawłowska I
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):575-7. PubMed ID: 826230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    Lai CC; Tan CK; Huang YT; Liao CH; Hsueh PR
    J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):487-90. PubMed ID: 807961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary antituberculous drug resistance in Hawaii, 1957 to 1977.
    Pien FD; Michael NL; Ow CL; Vennesland K; Brodsky ML
    Am Rev Respir Dis; 1978 Oct; 118(4):701-4. PubMed ID: 101107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
    Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to antituberculosis drugs in treated patients in Lagos, Nigeria.
    Idigbe EO; Duque JP; John EK; Annam O
    J Trop Med Hyg; 1992 Jun; 95(3):186-91. PubMed ID: 1597874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary drug resistance in adult pulmonary tuberculosis].
    Porven G; Rodriguez EJ; Piccolo R
    Medicina (B Aires); 1973; 3(6):708-15. PubMed ID: 4217868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.